Spinal muscular atrophy and related syndromes Clinical Trials

17 clinical trials for Spinal muscular atrophy and related syndromes across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Communication, speech, and language development in children (with neuromuscular disease): The first two years of life — RECRUITING
• Telemedical centre for out-of-hospital ventilation and oxygen therapy — RECRUITING
• Real-time magnetic resonance imaging (RT-MRI) for evaluating changes in swallowing, reflux, and lung mechanics in children with spinal muscular atrophy or Duchenne muscular dystrophy before and after spinal correction surgery — RECRUITING
• Register Muscle-Bone and Children's Rehabilitation — RECRUITING
• A Randomized, Double-Blind, PlaceboControlled, Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Participants with Spinal Muscular Atrophy with Open-Label Extension (RESILIENT) — RECRUITING
• Register study on neuroprognostics in patients with neurological / neurosurgical diseases in intensive care unit — RECRUITING
• Short term effects of nasal high flow therapy on autonomic nervous system function and respiration in patients with neuromuscular diseases — RECRUITING
• Effects of Nasal-High Flow therapy on nocturnal hypoventialtion and autonomic nervous system function in patients with neuromuscular diseases — RECRUITING
• Electrophysiological mapping of the motor cortex in disorders of the corticomotoneuronal and extrapyramidal motor systems — NOT_YET_RECRUITING
• Communicative situation of children with neuromuscular diseases — OTHER
• TANNE: Telemedicine responses to neuropalliative demands in real time — OTHER
• Retrospective analysis of patients’ records using the certified and approved Innowalk® to evaluate indication, usage, medical benefit and safety — OTHER
• Adherence in neurogeriatric patients — OTHER
• Health Related Quality of life in Patients with SMA — OTHER
• Evaluation of the ROBINA system regarding usability, acceptance and appropriateness. ROBINA endevaluation. — OTHER
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis — OTHER
• Phase II, multicenter, randomized, adaptive, double-blind,placebo controlled Study to assess Safety and Efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients — OTHER

Refine this search